// App-Quantinova.ai

1144-183 : ETIOLOGY, TIMING AND IMPACT OF DUAL ANTIPLATELET THERAPY DISCONTINUATION AFTER DRUG-ELUTING STENT IMPLANTATION: INSIGHTS FROM THE ADAPT-DES STUDY

Researchers

Presenter

  • Daniel Musikantowa

Principal Investigators

  • Ajay Kirtanea

  • Claire Litherlanda

  • Bernhard Witzenbichlera

  • Giora Weisza

  • Michael Rinaldia

  • David Metzgera

  • Timothy Henrya

  • David Coxa

  • Thomas Stuckeya

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Venous thrombosis

  • Trauma

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Clopidogrel bisulfate

  • Warfarin

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved